Clay illustration for Who gets MS

How common MS is

The 2024 update of the Atlas of MS, published in September 2026, estimates that 3.1 million people are living with MS worldwide, about 38 per 100,000 people or roughly one in every 2,600. Experts in 133 countries took part, and around 120,000 people are newly diagnosed each year. At least 40,000 of those living with MS are under 18.

Fiji: no data reportedTanzania: 0 per 100,000W. Sahara: no data reportedCanada: 290 per 100,000United States: 362 per 100,000Kazakhstan: 10.9 per 100,000Uzbekistan: no data reportedPapua New Guinea: no data reportedIndonesia: 0.3 per 100,000Argentina: 38 per 100,000Chile: 16 per 100,000Dem. Rep. Congo: no data reportedSomalia: no data reportedKenya: 0.6 per 100,000Sudan: 0.2 per 100,000Chad: no data reportedHaiti: 0.1 per 100,000Dominican Republic: 2.6 per 100,000Russia: 79.2 per 100,000Bahamas: no data reportedFalkland Is.: no data reportedNorway: 268 per 100,000Greenland: 48.3 per 100,000Fr. S. Antarctic Lands: no data reportedTimor-Leste: no data reportedSouth Africa: no data reportedLesotho: no data reportedMexico: 15 per 100,000Uruguay: 20.9 per 100,000Brazil: 18.9 per 100,000Bolivia: no data reportedPeru: 7.6 per 100,000Colombia: 7.5 per 100,000Panama: 9 per 100,000Costa Rica: 9 per 100,000Nicaragua: 1.3 per 100,000Honduras: 4.7 per 100,000El Salvador: no data reportedGuatemala: 3.4 per 100,000Belize: no data reportedVenezuela: 7.3 per 100,000Guyana: no data reportedSuriname: no data reportedFrance: 197.6 per 100,000Ecuador: 4 per 100,000Puerto Rico: 128.4 per 100,000Jamaica: no data reportedCuba: 14.5 per 100,000Zimbabwe: 0.1 per 100,000Botswana: no data reportedNamibia: 4 per 100,000Senegal: no data reportedMali: no data reportedMauritania: no data reportedBenin: no data reportedNiger: 0 per 100,000Nigeria: 0.9 per 100,000Cameroon: 0 per 100,000Togo: 0.2 per 100,000Ghana: 0.5 per 100,000Côte d'Ivoire: no data reportedGuinea: no data reportedGuinea-Bissau: no data reportedLiberia: no data reportedSierra Leone: no data reportedBurkina Faso: no data reportedCentral African Rep.: no data reportedCongo: no data reportedGabon: no data reportedEq. Guinea: no data reportedZambia: 0.1 per 100,000Malawi: 0 per 100,000Mozambique: no data reportedeSwatini: no data reportedAngola: no data reportedBurundi: no data reportedIsrael: 95 per 100,000Lebanon: 62.9 per 100,000Madagascar: no data reportedPalestine: 53 per 100,000Gambia: no data reportedTunisia: 58.3 per 100,000Algeria: 35 per 100,000Jordan: no data reportedUnited Arab Emirates: 18 per 100,000Qatar: 98 per 100,000Kuwait: 104.9 per 100,000Iraq: 22.6 per 100,000Oman: 15.9 per 100,000Vanuatu: no data reportedCambodia: no data reportedThailand: 0.8 per 100,000Laos: 0.1 per 100,000Myanmar: no data reportedVietnam: 4.1 per 100,000North Korea: no data reportedSouth Korea: 3.2 per 100,000Mongolia: no data reportedIndia: 10.9 per 100,000Bangladesh: no data reportedBhutan: no data reportedNepal: no data reportedPakistan: 5 per 100,000Afghanistan: no data reportedTajikistan: no data reportedKyrgyzstan: 5.5 per 100,000Turkmenistan: no data reportedIran: 121 per 100,000Syria: 43 per 100,000Armenia: 10.1 per 100,000Sweden: 215 per 100,000Belarus: 50 per 100,000Ukraine: 47.6 per 100,000Poland: 144 per 100,000Austria: 153.1 per 100,000Hungary: 130 per 100,000Moldova: 34 per 100,000Romania: 36.6 per 100,000Lithuania: 103.5 per 100,000Latvia: 106.7 per 100,000Estonia: 113.2 per 100,000Germany: 300 per 100,000Bulgaria: 121.2 per 100,000Greece: 197.8 per 100,000Turkey: 96.4 per 100,000Albania: 34 per 100,000Croatia: 143.8 per 100,000Switzerland: 207 per 100,000Luxembourg: no data reportedBelgium: 104 per 100,000Netherlands: 210.4 per 100,000Portugal: 143.4 per 100,000Spain: 123.3 per 100,000Ireland: 193.4 per 100,000New Caledonia: no data reportedSolomon Is.: no data reportedNew Zealand: 72.4 per 100,000Australia: 131.1 per 100,000Sri Lanka: 7.8 per 100,000China: 2.4 per 100,000Taiwan: 4.6 per 100,000Italy: 227 per 100,000Denmark: 306 per 100,000United Kingdom: 229 per 100,000Iceland: 212.4 per 100,000Azerbaijan: no data reportedGeorgia: 30 per 100,000Philippines: 28.8 per 100,000Malaysia: 5.7 per 100,000Brunei: 6.9 per 100,000Slovenia: 151.9 per 100,000Finland: 224 per 100,000Slovakia: 312.4 per 100,000Czech Republic: 249 per 100,000Eritrea: no data reportedJapan: 14.3 per 100,000Paraguay: 12 per 100,000Yemen: 1.7 per 100,000Saudi Arabia: 41 per 100,000N. Cyprus: no data reportedCyprus: 217 per 100,000Morocco: 20 per 100,000Egypt: 59 per 100,000Libya: 15 per 100,000Ethiopia: 0 per 100,000Djibouti: 1 per 100,000Somaliland: no data reportedUganda: no data reportedRwanda: no data reportedBosnia and Herzegovina: 91.4 per 100,000North Macedonia: 81.7 per 100,000Serbia: 176.4 per 100,000Montenegro: 135 per 100,000Kosovo: 52.6 per 100,000Trinidad and Tobago: no data reportedS. Sudan: no data reported

Point at a country to see its figure

People with MS per 100,0000 to 2526 to 5051 to 100101 to 200201 to 300Over 300No data
Figure. Reported MS prevalence by country, Atlas of MS 2024 update (118 countries). Lighter shading in parts of Africa and Asia partly reflects limited diagnosis and recording, not only lower risk. Small countries such as San Marino and Malta are too small to show at this scale.
The 2024 update of the Atlas of MS, published in September 2026, estimates that 3.1 million people are living with MS worldwide, about 38 per 100,000 people or roughly one in every 2,600. Experts in 133 countries took part, and around 120,000 people are newly diagnosed each year. At least 40,000 of those living with MS are under 18.

Women and men

About 7 in 10 people with MS are women, a pattern seen in every region and income group, although the share varies from about 30% to almost 90% between countries. Symptoms most often begin in early adult life, with an average age at diagnosis of about 32 worldwide.

7 women3 men
Figure. Of every 10 people with MS worldwide, about 7 are women.

Where MS is most common, and the rise over time

Prevalence is highest in Europe and the Americas and lowest in Africa, the Western Pacific and South-East Asia, and it is higher in high-income countries. Within many regions it also rises with distance from the equator, a gradient confirmed by meta-analysis and one reason sunlight and vitamin D are studied as risk factors.

The number of people living with MS has risen from about 1.8 million in 2013 to 3.1 million in 2024, and prevalence from 25 to 38 per 100,000, when all three years are calculated the same way. Earlier and more accurate diagnosis, longer survival with better treatment and care, stronger data systems and population growth all contribute, which is in part a sign of progress. A true rise in risk cannot be ruled out: several countries report a growing share of women among new diagnoses, while new diagnoses worldwide show no single clear trend.

These figures carry real uncertainty. Many low- and middle-income countries have little or no registry data, so lower reported prevalence there can partly reflect missing information rather than absence of disease.

Children and older adults

MS can begin in childhood. The Atlas of MS estimates that at least 40,000 people under 18 are living with MS. It can also begin later in life. The 2024 diagnostic criteria include specific guidance for people aged 50 or over, and age does not rule out a diagnosis.

In the research now

Loading current research…

References

  1. MSIF · Atlas of MS 2024 epidemiology report
  2. MSIF · Atlas of MS 2024 epidemiology update
  3. Walton et al. · Rising prevalence of multiple sclerosis worldwide: insights from the Atlas of MS, third edition. Mult Scler (2020)
  4. GBD 2016 Multiple Sclerosis Collaborators (Wallin et al.) · Global, regional, and national burden of multiple sclerosis 1990–2016. Lancet Neurol (2019)
  5. Simpson et al. · Latitude is significantly associated with the prevalence of multiple sclerosis: a meta-analysis. J Neurol Neurosurg Psychiatry (2011)
  6. Koch-Henriksen & Sørensen · The changing demographic pattern of multiple sclerosis epidemiology. Lancet Neurol (2010)
  7. Montalban et al. · Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria (published 2025)
  8. MSIF · Atlas of MS 2024 country data

Next module · Conditions that resemble MS

Conditions that resemble MS

Several diseases can look like MS on an examination or a scan, and some are treated very differently. This lesson explains the most common ones, how often MS is wrongly diagnosed, and why the difference matters.

Continue
← Previous: Genetics of susceptibility and severity

Assembled by software from public sources and not checked by people. Each record links to its source. Report an error